Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Brassica vegetables (such as broccoli, cabbage, Brussels sprouts, and kale) have been investigated for their potential to support or treat Inflammatory Bowel Disorders (IBD), including Crohn’s disease and ulcerative colitis. The scientific interest in Brassica arises from their high content of glucosinolates and their breakdown products (e.g., sulforaphane), as well as dietary fiber and polyphenols. These compounds have demonstrated anti-inflammatory, antioxidant, and gut microbiota-modulating effects in preclinical studies.

Animal studies and in vitro experiments indicate that Brassica extracts can reduce markers of intestinal inflammation, decrease oxidative stress, and help maintain the gut barrier. For example, sulforaphane has been shown to inhibit NF-κB signaling—a key pathway in gut inflammation. Additionally, some studies suggest Brassica-derived fiber can increase beneficial gut bacteria and short-chain fatty acid production, both relevant to gut health.

However, clinical evidence in humans is limited and sometimes conflicting. Small pilot studies have reported some symptomatic improvement or changes in inflammatory markers with Brassica-rich diets, but robust, large-scale clinical trials are lacking. Some individuals with IBD may also experience symptom exacerbation from high-fiber vegetables during active flare-ups. Thus, while there is a promising mechanistic rationale and preliminary evidence, more high-quality human research is needed before Brassica can be definitively recommended as a central therapy for IBD.

More about Brassica
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by Brassica

Products containing Brassica